World Sepsis Day on September 13, 2024
On the occasion of World Sepsis Day on September 13, we want to raise awareness about sepsis, a life-threatening condition that impacts millions globally each year.
News
The OCCIDENT Team explores Milan
This year's team offsite event in Milan gave us the opportunity to enjoy the Italian way of life at its best.
Celebrating 10 years of Cédric at OCCIDENT
We are proud that Cédric has accompanied us over the last ten years and would like to take this opportunity to say THANK YOU to him!
OCCIDENT Launches Project Study Opportunity for TUM Students
We provide an exceptional opportunity for students at the Technical University of Munich to gain hands-on experience in venture capital while earning credits towards their Master's programs.
Tubulis Receives FDA Fast Track Designation
Tubulis' TUB-040, an ADC for platinum-resistant ovarian cancer, receives FDA Fast Track, expediting its development in Phase I/IIa trials to address urgent cancer treatment needs.
Tubulis Doses First Patient in Phase I/IIa Trial for TUB-040
UB-040 targets an overexpressed antigen in ovarian and lung adenocarcinoma. The trial will enroll up to 140 patients across the US, UK, and Europe.
OCCIDENT Insights: We improve communication
The OCCIDENT Team regularly improves its soft skills to enhance collaboration both internally and externally. In addition to our professional skills, we attach great importance to teamwork.
Avelo collaborates with global health leaders in project “BreathForDiagnosis”
The €3 million research project is funded by the European Commission under "Horizon Europe", and co-funded by the Swiss State Secretariat for Education, Research and Innovation (SERI).
Moments to Remember: 4th OCCIDENT Pitch Event in Munich
Thank you for inspiring pitches, engaging conversations, and meaningful connections